Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
about
Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers.Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.Imaging and fluid biomarkers in frontotemporal dementia.An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations.Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay.Peripheral nerve atrophy together with higher cerebrospinal fluid progranulin indicate axonal damage in amyotrophic lateral sclerosis.Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
P2860
Q31141202-F1571DB2-610C-4A2D-81C3-77CB2C1AC31BQ37293615-54E3E49F-56DF-4B98-90D7-C0D09B7FD9CEQ38392505-69158FEF-04B4-4D0E-A2D9-BA9B832C846DQ38670219-1A4BCA7F-FEFC-41E7-ACE6-E047D8624769Q43557976-473D17C2-98EA-4232-825D-E57BC8558E70Q50532320-0AC326E3-BFF2-4AF7-B18E-ECEB4989CD33Q50888839-706464A4-7764-422E-8BA6-ACBAF88DA7F0Q52646410-5ABAFC58-1ED3-4A01-8CC4-F25C620C84DF
P2860
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
@en
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
@nl
type
label
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
@en
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
@nl
prefLabel
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
@en
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
@nl
P2093
P2860
P1476
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
@en
P2093
Albert Christian Ludolph
Alexander Erich Volk
Emily Feneberg
Hayrettin Tumani
Jochen Hans Weishaupt
Marc Axel Wollmer
Markus Otto
Petra Steinacker
P2860
P2888
P304
P356
10.1007/S00702-015-1486-1
P50
P577
2015-12-11T00:00:00Z